Cipla - Quaterly Results

27 Oct 2023 Evaluate
The company witnessed a 12.37% growth in the revenue at Rs. 46647.20 millions for the quarter ended September 2023 as compared to Rs. 41512.70 millions during the year-ago period.Net Profit recorded in the quarter ended September 2023 rise to 46.02% to Rs. 10296.90  millions  compared to R. 7051.90 millions in corresponding previous quarter.Operating profit for the quarter ended September 2023 rose to 15842.10 millions as compared to 11533.30 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 46647.20 41512.70 12.37 89829.10 79974.10 12.32 157906.00 153808.20 2.66
Other Income 2050.90 922.80 122.25 3630.70 2099.60 72.92 4567.90 6667.00 -31.48
PBIDT 15842.10 11533.30 37.36 29468.80 22646.50 30.13 42493.70 43779.30 -2.94
Interest 78.00 75.00 4.00 81.10 97.10 -16.48 270.20 269.30 0.33
PBDT 15764.10 11458.30 37.58 29387.70 22549.40 30.33 40364.50 43510.00 -7.23
Depreciation 1798.10 1760.10 2.16 3157.60 3043.70 3.74 5959.10 5466.20 9.02
PBT 13966.00 9698.20 44.01 26230.10 19505.70 34.47 34405.40 38043.80 -9.56
TAX 3669.10 2646.30 38.65 6983.00 5150.50 35.58 9710.10 9218.00 5.34
Deferred Tax -13.00 -6.00 116.67 -102.50 -95.30 7.56 -400.90 -276.90 44.78
PAT 10296.90 7051.90 46.02 19247.10 14355.20 34.08 24695.30 28825.80 -14.33
Equity 1614.70 1614.00 0.04 1614.70 1614.00 0.04 1614.30 1613.60 0.04
PBIDTM(%) 33.96 27.78 22.24 32.81 28.32 15.85 26.91 28.46 -5.46

Cipla Share Price

1475.90 -0.55 (-0.04%)
24-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1817.60
Dr. Reddys Lab 1351.25
Cipla 1475.90
Lupin 2168.30
Zydus Lifesciences 964.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.